Skip to main content
SpringerLink
Log in

The CCL5/CCR5 Axis in Cancer

  • Chapter
  • First Online:
Chemokine Receptors in Cancer

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

The multifaceted roles of chemokines and of their receptors in physiological and pathological conditions have motivated researchers to analyze their involvement also in malignant diseases. This chapter focuses on CCL5 (RANTES) and its CCR5 receptor in cancer, describing their expression patterns, activities, and roles in several malignancies. Thus far, CCL5 and/or CCR5 have been detected in many hematological malignancies and in a large number of solid tumors; however, extensive studies on CCL5 and CCR5 were performed only in a limited number of cancers, including primarily multiple myeloma, breast cancer, and melanoma. This chapter discusses the major findings in these three specific malignancies, and addresses other cancers in which preliminary evidence was provided, including gastric cancer and ovarian cancer. In the framework of this chapter, we discuss the expression patterns of CCL5 and CCR5 in patients, their associations with disease course and experiments that were performed in animal model systems in order to decipher the roles of the CCL5/CCR5 axis in tumor growth and metastasis. In addition, we describe possible mechanisms mediating the activity of this pair in specific malignancies, and their effects on the tumor cells and on cells of the tumor microenvironment. Also, when it is of relevance, we consider the roles of other receptors for CCL5 (CCR1, CCR3) and of additional high-affinity chemotactic ligands for CCR5 (MIP-1α, CCL3; MIP-1β, CCL4). Taken together, the different studies suggest that even if the CCL5/CCR5 axis may have an anti-tumor potential under specific conditions, it turns into a detrimental entity in defined cancer diseases, such as multiple myeloma and breast cancer. Overall, CCL5/CCR5 may have major implications in cancer, and they should be considered as potential therapeutic targets for the limitation of specific malignant diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ben-Baruch, A. 2006. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25:357.

    Article  PubMed  CAS  Google Scholar 

  2. Conti, I., and B. J. Rollins. 2004. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14:149.

    Article  PubMed  CAS  Google Scholar 

  3. Zlotnik, A. 2006. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13:191.

    Article  PubMed  CAS  Google Scholar 

  4. Strieter, R. M., M. D. Burdick, J. Mestas, B. Gomperts, M. P. Keane, and J. A. Belperio. 2006. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42:768.

    Article  PubMed  CAS  Google Scholar 

  5. Ben-Baruch, A. 2006. Pro-malignancy and putative anti-malignancy chemokines in the regulation of breast cancer progression. Nova Science Publishers.

    Google Scholar 

  6. Ben-Baruch, A. 2006. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16:38.

    Article  PubMed  CAS  Google Scholar 

  7. Ben-Baruch, A. 2008. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345.

    Google Scholar 

  8. Wong, M. M., and E. N. Fish. 2003. Chemokines: attractive mediators of the immune response. Semin Immunol 15:5.

    Article  PubMed  CAS  Google Scholar 

  9. Mueller, A., and P. G. Strange. 2004. The chemokine receptor, CCR5. Int J Biochem Cell Biol 36:35.

    Article  PubMed  CAS  Google Scholar 

  10. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat Immunol 2:102.

    Article  PubMed  CAS  Google Scholar 

  11. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593.

    Article  PubMed  CAS  Google Scholar 

  12. Mackay, C. R., and F. Sallusto. 2006. A new role for CCR5 in innate immunity--binding to bacterial heat shock protein 70. Eur J Immunol 36:2293.

    Article  PubMed  CAS  Google Scholar 

  13. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145.

    PubMed  CAS  Google Scholar 

  14. Bacon, K., M. Baggiolini, H. Broxmeyer, R. Horuk, I. Lindley, A. Mantovani, K. Maysushima, P. Murphy, H. Nomiyama, J. Oppenheim, A. Rot, T. Schall, M. Tsang, R. Thorpe, J. Van Damme, M. Wadhwa, O. Yoshie, A. Zlotnik, and K. Zoon. 2002. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067.

    Article  PubMed  Google Scholar 

  15. Devalaraja, M. N., and A. Richmond. 1999. Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol Sci 20:151.

    Article  PubMed  CAS  Google Scholar 

  16. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol Today 20:254.

    Article  PubMed  CAS  Google Scholar 

  17. Abe, M., K. Hiura, J. Wilde, K. Moriyama, T. Hashimoto, S. Ozaki, S. Wakatsuki, M. Kosaka, S. Kido, D. Inoue, and T. Matsumoto. 2002. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 100:2195.

    PubMed  CAS  Google Scholar 

  18. Oba, Y., J. W. Lee, L. A. Ehrlich, H. Y. Chung, D. F. Jelinek, N. S. Callander, R. Horuk, S. J. Choi, and G. D. Roodman. 2005. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol 33:272.

    Article  PubMed  CAS  Google Scholar 

  19. Menu, E., E. De Leenheer, H. De Raeve, L. Coulton, T. Imanishi, K. Miyashita, E. Van Valckenborgh, I. Van Riet, B. Van Camp, R. Horuk, P. Croucher, and K. Vanderkerken. 2006. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin Exp Metastasis 23:291.

    Article  PubMed  CAS  Google Scholar 

  20. Choi, S. J., J. C. Cruz, F. Craig, H. Chung, R. D. Devlin, G. D. Roodman, and M. Alsina. 2000. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96:671.

    PubMed  CAS  Google Scholar 

  21. Lentzsch, S., M. Gries, M. Janz, R. Bargou, B. Dorken, and M. Y. Mapara. 2003. Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 101:3568.

    Article  PubMed  CAS  Google Scholar 

  22. Hashimoto, T., M. Abe, T. Oshima, H. Shibata, S. Ozaki, D. Inoue, and T. Matsumoto. 2004. Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma. Br J Haematol 125:38.

    Article  PubMed  CAS  Google Scholar 

  23. Terpos, E., M. Politou, R. Szydlo, J. M. Goldman, J. F. Apperley, and A. Rahemtulla. 2003. Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma. Br J Haematol 123:106.

    Article  PubMed  CAS  Google Scholar 

  24. Terpos, E., M. Politou, N. Viniou, and A. Rahemtulla. 2005. Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma 46:1699.

    Article  PubMed  CAS  Google Scholar 

  25. Choi, S. J., Y. Oba, Y. Gazitt, M. Alsina, J. Cruz, J. Anderson, and G. D. Roodman. 2001. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 108:1833.

    PubMed  CAS  Google Scholar 

  26. Lentzsch, S., M. Chatterjee, M. Gries, K. Bommert, H. Gollasch, B. Dorken, and R. C. Bargou. 2004. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 18:1883.

    Article  PubMed  CAS  Google Scholar 

  27. Han, J. H., S. J. Choi, N. Kurihara, M. Koide, Y. Oba, and G. D. Roodman. 2001. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97:3349.

    Article  PubMed  CAS  Google Scholar 

  28. Trentin, L., M. Miorin, M. Facco, I. Baesso, S. Carraro, A. Cabrelle, N. Maschio, M. Bortoli, G. Binotto, F. Piazza, F. Adami, R. Zambello, C. Agostini, and G. Semenzato. 2007. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity. Br J Haematol 138:594.

    Article  PubMed  CAS  Google Scholar 

  29. Moller, C., T. Stromberg, M. Juremalm, K. Nilsson, and G. Nilsson. 2003. Expression and function of chemokine receptors in human multiple myeloma. Leukemia 17:203.

    Article  PubMed  CAS  Google Scholar 

  30. Luboshits, G., S. Shina, O. Kaplan, S. Engelberg, D. Nass, B. Lifshitz-Mercer, S. Chaitchik, I. Keydar, and A. Ben-Baruch. 1999. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59:4681.

    PubMed  CAS  Google Scholar 

  31. Niwa, Y., H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki, and A. Abe. 2001. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7:285.

    PubMed  CAS  Google Scholar 

  32. Yaal-Hahoshen, N., S. Shina, L. Leider-Trejo, I. Barnea, E. L. Shabtai, E. Azenshtein, I. Greenberg, I. Keydar, and A. Ben-Baruch. 2006. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 12:4474.

    Article  PubMed  CAS  Google Scholar 

  33. Bieche, I., F. Lerebours, S. Tozlu, M. Espie, M. Marty, and R. Lidereau. 2004. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 10:6789.

    Article  PubMed  CAS  Google Scholar 

  34. Tedla, N., P. Palladinetti, D. Wakefield, and A. Lloyd. 1999. Abundant expression of chemokines in malignant and infective human lymphadenopathies. Cytokine 11:531.

    Article  PubMed  CAS  Google Scholar 

  35. Celis, J. E., P. Gromov, T. Cabezon, J. M. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova. 2004. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 3:327.

    Article  PubMed  CAS  Google Scholar 

  36. Dehqanzada, Z. A., C. E. Storrer, M. T. Hueman, R. J. Foley, K. A. Harris, Y. H. Jama, C. D. Shriver, S. Ponniah, and G. E. Peoples. 2007. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep 17:687.

    PubMed  CAS  Google Scholar 

  37. Eissa, S. A., S. A. Zaki, S. M. El-Maghraby, and D. Y. Kadry. 2005. Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst 17:51.

    PubMed  Google Scholar 

  38. Wigler, N., S. Shina, O. Kaplan, G. Luboshits, S. Chaitchik, I. Keydar, and A. Ben-Baruch. 2002. Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease. Isr Med Assoc J 4:940.

    PubMed  Google Scholar 

  39. Karnoub, A. E., A. B. Dash, A. P. Vo, A. Sullivan, M. W. Brooks, G. W. Bell, A. L. Richardson, K. Polyak, R. Tubo, and R. A. Weinberg. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557.

    Article  PubMed  CAS  Google Scholar 

  40. Azenshtein, E., G. Luboshits, S. Shina, E. Neumark, D. Shahbazian, M. Weil, N. Wigler, I. Keydar, and A. Ben-Baruch. 2002. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 62:1093.

    PubMed  CAS  Google Scholar 

  41. Azenshtein, E., T. Meshel, S. Shina, N. Barak, I. Keydar, and A. Ben-Baruch. 2005. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett 217:73.

    Article  PubMed  CAS  Google Scholar 

  42. Kurt, R. A., A. Baher, K. P. Wisner, S. Tackitt, and W. J. Urba. 2001. Chemokine receptor desensitization in tumor-bearing mice. Cell Immunol 207:81.

    Article  PubMed  CAS  Google Scholar 

  43. Mira, E., R. A. Lacalle, M. A. Gonzalez, C. Gomez-Mouton, J. L. Abad, A. Bernad, A. C. Martinez, and S. Manes. 2001. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep 2:151.

    Article  PubMed  CAS  Google Scholar 

  44. Cappellen, D., T. Schlange, M. Bauer, F. Maurer, and N. E. Hynes. 2007. Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep 8:70.

    Article  PubMed  CAS  Google Scholar 

  45. Dupre, S. A., D. Redelman, and K. W. Hunter, Jr. 2007. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int J Exp Pathol 88:351.

    Article  PubMed  CAS  Google Scholar 

  46. Stormes, K. A., C. A. Lemken, J. V. Lepre, M. N. Marinucci, and R. A. Kurt. 2005. Inhibition of metastasis by inhibition of tumor-derived CCL5. Breast Cancer Res Treat 89:209.

    Article  PubMed  CAS  Google Scholar 

  47. Adler, E. P., C. A. Lemken, N. S. Katchen, and R. A. Kurt. 2003. A dual role for tumor-derived chemokine RANTES (CCL5). Immunol Lett 90:187.

    Article  PubMed  CAS  Google Scholar 

  48. Robinson, S. C., K. A. Scott, J. L. Wilson, R. G. Thompson, A. E. Proudfoot, and F. R. Balkwill. 2003. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 63:8360.

    PubMed  CAS  Google Scholar 

  49. Ali, S., J. Kaur, and K. D. Patel. 2000. Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol 157:313.

    Article  PubMed  CAS  Google Scholar 

  50. de Silva, E., and M. P. Stumpf. 2004. HIV and the CCR5-Delta32 resistance allele. FEMS Microbiol Lett 241:1.

    Article  PubMed  CAS  Google Scholar 

  51. Manes, S., E. Mira, R. Colomer, S. Montero, L. M. Real, C. Gomez-Mouton, S. Jimenez-Baranda, A. Garzon, R. A. Lacalle, K. Harshman, A. Ruiz, and A. C. Martinez. 2003. CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med 198:1381.

    Article  PubMed  CAS  Google Scholar 

  52. Degerli, N., E. Yilmaz, and F. Bardakci. 2005. The Delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population. Clin Biochem 38:248.

    Article  PubMed  CAS  Google Scholar 

  53. Ghilardi, G., M. L. Biondi, A. La Torre, L. Battaglioli, and R. Scorza. 2005. Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele. Clin Chem 51:452.

    Article  PubMed  CAS  Google Scholar 

  54. Zafiropoulos, A., N. Crikas, A. M. Passam, and D. A. Spandidos. 2004. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41: e59.

    Article  PubMed  CAS  Google Scholar 

  55. Jayasinghe, M. M., J.M. Golden, P. Nair, C. M. O'Donnell, M. T. Werner, and R. A. Kurt. 2008. Tumor-derived CCL5 does not contribute to breast cancer progression. Breast Cancer Res Treat 111:511.

    Google Scholar 

  56. Prest, S. J., R. C. Rees, C. Murdoch, J. F. Marshall, P. A. Cooper, M. Bibby, G. Li, and S. A. Ali. 1999. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin Exp Metastasis 17:389.

    Article  PubMed  CAS  Google Scholar 

  57. Youngs, S. J., S. A. Ali, D. D. Taub, and R. C. Rees. 1997. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71:257.

    Article  PubMed  CAS  Google Scholar 

  58. Aronica, S. M., P. Fanti, K. Kaminskaya, K. Gibbs, L. Raiber, M. Nazareth, R. Bucelli, M. Mineo, K. Grzybek, M. Kumin, K. Poppenberg, C. Schwach, and K. Janis. 2004. Estrogen disrupts chemokine-mediated chemokine release from mammary cells: implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation. Breast Cancer Res Treat 84:235.

    Article  PubMed  CAS  Google Scholar 

  59. Khodarev, N. N., J. Yu, E. Labay, T. Darga, C. K. Brown, H. J. Mauceri, R. Yassari, N. Gupta, and R. R. Weichselbaum. 2003. Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116:1013.

    Article  PubMed  CAS  Google Scholar 

  60. Sun, X. T., M. Y. Zhang, C. Shu, Q. Li, X. G. Yan, N. Cheng, Y. D. Qiu, and Y. T. Ding. 2005. Differential gene expression during capillary morphogenesis in a microcarrier-based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors. World J Gastroenterol 11:2283.

    PubMed  CAS  Google Scholar 

  61. Mantovani, A., P. Allavena, and A. Sica. 2004. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40:1660.

    Article  PubMed  CAS  Google Scholar 

  62. Mantovani, A., W. J. Ming, C. Balotta, B. Abdeljalil, and B. Bottazzi. 1986. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta 865:59.

    PubMed  CAS  Google Scholar 

  63. Leek, R. D., and A. L. Harris. 2002. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7:177.

    Article  PubMed  Google Scholar 

  64. Lin, E. Y., and J. W. Pollard. 2004. Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158.

    Article  PubMed  CAS  Google Scholar 

  65. Bingle, L., C. E. Lewis, K. P. Corke, M. W. Reed, and N. J. Brown. 2006. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94:101.

    Article  PubMed  CAS  Google Scholar 

  66. Wyckoff, J., W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall, and J. Condeelis. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64:7022.

    Article  PubMed  CAS  Google Scholar 

  67. Bolat, F., F. Kayaselcuk, T. Z. Nursal, M. C. Yagmurdur, N. Bal, and B. Demirhan. 2006. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 25:365.

    PubMed  CAS  Google Scholar 

  68. Robinson, S. C., K. A. Scott, and F. R. Balkwill. 2002. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 32:404.

    Article  PubMed  CAS  Google Scholar 

  69. Klier, C. M., E. L. Nelson, C. D. Cohen, R. Horuk, D. Schlondorff, and P. J. Nelson. 2001. Chemokine-Induced secretion of gelatinase B in primary human monocytes. Biol Chem 382:1405.

    Article  PubMed  CAS  Google Scholar 

  70. Locati, M., U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani. 2002. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 168:3557.

    PubMed  CAS  Google Scholar 

  71. Challita-Eid, P. M., C. N. Abboud, S. L. Morrison, M. L. Penichet, K. E. Rosell, T. Poles, S. P. Hilchey, V. Planelles, and J. D. Rosenblatt. 1998. A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunol 161:3729.

    PubMed  CAS  Google Scholar 

  72. Manjili, M. H., H. Arnouk, K. L. Knutson, M. Kmieciak, M. L. Disis, J. R. Subjeck, and A. L. Kazim. 2006. Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Res Treat 96:233.

    Article  PubMed  CAS  Google Scholar 

  73. Di Carlo, E., P. Cappello, C. Sorrentino, T. D'Antuono, A. Pellicciotta, M. Giovarelli, G. Forni, P. Musiani, and F. Triebel. 2005. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway. J Pathol 205:82.

    Article  PubMed  CAS  Google Scholar 

  74. Nath, A., S. Chattopadhya, U. Chattopadhyay, and N. K. Sharma. 2006. Macrophage inflammatory protein (MIP)1alpha and MIP1beta differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy. Cancer Immunol Immunother 55:1534.

    Article  PubMed  CAS  Google Scholar 

  75. Roda, J. M., R. Parihar, C. Magro, G. J. Nuovo, S. Tridandapani, and W. E. Carson, 3rd. 2006. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res 66:517.

    Article  PubMed  CAS  Google Scholar 

  76. Payne, A. S., and L. A. Cornelius. 2002. The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118:915.

    Article  PubMed  CAS  Google Scholar 

  77. Hussein, M. R. 2005. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight. Br J Dermatol 153:18.

    Article  PubMed  CAS  Google Scholar 

  78. Kawakami, Y., and S. A. Rosenberg. 1997. Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy. Int Rev Immunol 14:173.

    Article  PubMed  CAS  Google Scholar 

  79. Kawakami, Y., M. I. Nishimura, N. P. Restifo, S. L. Topalian, B. H. O'Neil, J. Shilyansky, J. R. Yannelli, and S. A. Rosenberg. 1993. T-cell recognition of human melanoma antigens. J Immunother Emphasis Tumor Immunol 14:88.

    Article  PubMed  CAS  Google Scholar 

  80. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, M. Roederer, and M. M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5:677.

    Article  PubMed  CAS  Google Scholar 

  81. Mrowietz, U., U. Schwenk, S. Maune, J. Bartels, M. Kupper, I. Fichtner, J. M. Schroder, and D. Schadendorf. 1999. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 79:1025.

    Article  PubMed  CAS  Google Scholar 

  82. Mattei, S., M. P. Colombo, C. Melani, A. Silvani, G. Parmiani, and M. Herlyn. 1994. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853.

    Article  PubMed  CAS  Google Scholar 

  83. Kershaw, M. H., G. Wang, J. A. Westwood, R. K. Pachynski, H. L. Tiffany, F. M. Marincola, E. Wang, H. A. Young, P. M. Murphy, and P. Hwu. 2002. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Hum Gene Ther 13:1971.

    Article  PubMed  CAS  Google Scholar 

  84. Kunz, M., A. Toksoy, M. Goebeler, E. Engelhardt, E. Brocker, and R. Gillitzer. 1999. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J Pathol 189:552.

    Article  PubMed  CAS  Google Scholar 

  85. Seidl, H., E. Richtig, H. Tilz, M. Stefan, U. Schmidbauer, M. Asslaber, K. Zatloukal, M. Herlyn, and H. Schaider. 2007. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 38:768.

    Article  PubMed  CAS  Google Scholar 

  86. Dobrzanski, M. J., J. B. Reome, and R. W. Dutton. 2001. Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection. Clin Immunol 98:70.

    Article  PubMed  CAS  Google Scholar 

  87. Mellado, M., A. M. de Ana, M. C. Moreno, C. Martinez, and J. M. Rodriguez-Frade. 2001. A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr Biol 11:691.

    Article  PubMed  CAS  Google Scholar 

  88. Ng-Cashin, J., J. J. Kuhns, S. E. Burkett, J. D. Powderly, R. R. Craven, H. W. van Deventer, S. L. Kirby, and J. S. Serody. 2003. Host absence of CCR5 potentiates dendritic cell vaccination. J Immunol 170:4201.

    PubMed  CAS  Google Scholar 

  89. van Deventer, H. W., W. O'Connor, Jr., W. J. Brickey, R. M. Aris, J. P. Ting, and J. S. Serody. 2005. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Res 65:3374.

    PubMed  Google Scholar 

  90. Wysocki, C. A., A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody. 2005. Leukocyte migration and graft-versus-host disease. Blood 105:4191.

    Article  PubMed  CAS  Google Scholar 

  91. Rodero, M., P. Rodero, V. Descamps, C. Lebbe, P. Wolkenstein, P. Aegerter, D. Vitoux, N. Basset-Seguin, N. Dupin, B. Grandchamp, N. Soufir, C. Combadiere, and P. Saiag. 2007. Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5). J Dermatol Sci 46:72.

    Article  PubMed  CAS  Google Scholar 

  92. Ugurel, S., D. Schrama, G. Keller, D. Schadendorf, E. B. Brocker, R. Houben, M. Zapatka, W. Fink, H. L. Kaufman, and J. C. Becker. 2008. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy. Cancer Immunol Immunother 57:685.

    Google Scholar 

  93. Padovan, E., L. Terracciano, U. Certa, B. Jacobs, A. Reschner, M. Bolli, G. C. Spagnoli, E. C. Borden, and M. Heberer. 2002. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res 62:3453.

    PubMed  CAS  Google Scholar 

  94. Chen, Z., T. Moyana, A. Saxena, R. Warrington, Z. Jia, and J. Xiang. 2001. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer 93:539.

    Article  PubMed  CAS  Google Scholar 

  95. Kim, H. K., K. S. Song, Y. S. Park, Y. H. Kang, Y. J. Lee, K. R. Lee, K. W. Ryu, J. M. Bae, and S. Kim. 2003. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184.

    Article  PubMed  CAS  Google Scholar 

  96. Fukui, R., H. Nishimori, F. Hata, T. Yasoshima, K. Ohno, H. Nomura, Y. Yanai, H. Tanaka, K. Kamiguchi, R. Denno, N. Sato, and K. Hirata. 2005. Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer. J Surg Res 129:94.

    Article  PubMed  CAS  Google Scholar 

  97. Hahm, K. B., Y. J. Song, T. Y. Oh, J. S. Lee, Y. J. Surh, Y. B. Kim, B. M. Yoo, J. H. Kim, S. U. Han, K. T. Nahm, M. W. Kim, D. Y. Kim, and S. W. Cho. 2003. Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J Biochem Mol Biol 36:82.

    Article  PubMed  CAS  Google Scholar 

  98. Okita, K., T. Furuhata, Y. Kimura, M. Kawakami, K. Yamaguchi, T. Tsuruma, H. Zembutsu, and K. Hirata. 2005. The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression. J Exp Clin Cancer Res 24:439.

    PubMed  CAS  Google Scholar 

  99. Ohtani, N., H. Ohtani, T. Nakayama, H. Naganuma, E. Sato, T. Imai, H. Nagura, and O. Yoshie. 2004. Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis. Lab Invest 84:368.

    Article  PubMed  CAS  Google Scholar 

  100. Burke, F., M. Relf, R. Negus, and F. Balkwill. 1996. A cytokine profile of normal and malignant ovary. Cytokine 8:578.

    Article  PubMed  CAS  Google Scholar 

  101. Melani, C., S. M. Pupa, A. Stoppacciaro, S. Menard, M. I. Colnaghi, G. Parmiani, and M. P. Colombo. 1995. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer 62:572.

    Article  PubMed  CAS  Google Scholar 

  102. Negus, R. P., G. W. Stamp, J. Hadley, and F. R. Balkwill. 1997. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150:1723.

    PubMed  CAS  Google Scholar 

  103. Simonitsch, I., and G. Krupitza. 1998. Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha). Br J Cancer 78:862.

    Article  PubMed  CAS  Google Scholar 

  104. Tsukishiro, S., N. Suzumori, H. Nishikawa, A. Arakawa, and K. Suzumori. 2006. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Gynecol Oncol 102:542.

    Article  PubMed  CAS  Google Scholar 

  105. Milliken, D., C. Scotton, S. Raju, F. Balkwill, and J. Wilson. 2002. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res 8:1108.

    PubMed  CAS  Google Scholar 

  106. Dong, H. P., M. B. Elstrand, A. Holth, I. Silins, A. Berner, C. G. Trope, B. Davidson, and B. Risberg. 2006. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 125:451.

    PubMed  Google Scholar 

  107. Uekusa, Y., W. G. Yu, T. Mukai, P. Gao, N. Yamaguchi, M. Murai, K. Matsushima, S. Obika, T. Imanishi, Y. Higashibata, S. Nomura, Y. Kitamura, H. Fujiwara, and T. Hamaoka. 2002. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice. Cancer Res 62:3751.

    PubMed  CAS  Google Scholar 

  108. Hagemann, T., J. Wilson, F. Burke, H. Kulbe, N. F. Li, A. Pluddemann, K. Charles, S. Gordon, and F. R. Balkwill. 2006. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 176:5023.

    PubMed  CAS  Google Scholar 

  109. Yoong, K. F., S. C. Afford, R. Jones, P. Aujla, S. Qin, K. Price, S. G. Hubscher, and D. H. Adams. 1999. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 30:100.

    Article  PubMed  CAS  Google Scholar 

  110. Liu, Y., R. T. Poon, J. Hughes, X. Feng, W. C. Yu, and S. T. Fan. 2005. Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma. Clin Immunol 114:174.

    Article  PubMed  CAS  Google Scholar 

  111. Liu, Y., R. T. Poon, X. Feng, W. C. Yu, J. M. Luk, and S. T. Fan. 2004. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Am J Gastroenterol 99:1111.

    Article  PubMed  CAS  Google Scholar 

  112. Shin, E. C., Y. H. Choi, J. S. Kim, S. J. Kim, and J. H. Park. 2002. Expression patterns of cytokines and chemokines genes in human hepatoma cells. Yonsei Med J 43:657.

    PubMed  CAS  Google Scholar 

  113. Ruan, Y., Y. Guan, Z. Wu, Z. Zhang, and C. Zheng. 2003. The relationship between RANTES and mast cells recruitment in the surroundings of intrahepatic implanted tumors. Clin Lab 49:65.

    PubMed  CAS  Google Scholar 

  114. Nahon, P., A. Sutton, P. Rufat, C. Faisant, C. Simon, N. Barget, J. C. Trinchet, M. Beaugrand, L. Gattegno, and N. Charnaux. 2007. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 19:425.

    Article  PubMed  CAS  Google Scholar 

  115. Hirano, S., Y. Iwashita, A. Sasaki, S. Kai, M. Ohta, and S. Kitano. 2007. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. J Gastroenterol Hepatol 22:690.

    PubMed  CAS  Google Scholar 

  116. Lu, P., Y. Nakamoto, Y. Nemoto-Sasaki, C. Fujii, H. Wang, M. Hashii, Y. Ohmoto, S. Kaneko, K. Kobayashi, and N. Mukaida. 2003. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 162:1249.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The relevant research to this paper, which is performed in the authors’ laboratory, is supported by The Israel Academy of Sciences and Humanities; The Israel Cancer Association; The Israel Ministry of Health; The Ela Kodesz Institute for Research on Cancer Development and Prevention; The Federico Foundation. The authors thank the members of the laboratory and collaborators who have contributed to the studies on chemokines in malignancy and in inflammation.

Author information

Authors and Affiliations

  1. Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel

    Gali Soria & Adit Ben-Baruch

Authors
  1. Gali Soria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adit Ben-Baruch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adit Ben-Baruch .

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Humana Press, a part of Springer Science+Business Media, LLC

    About this chapter

    Cite this chapter

    Soria, G., Ben-Baruch, A. (2009). The CCL5/CCR5 Axis in Cancer. In: Fulton, A. (eds) Chemokine Receptors in Cancer. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60327-267-4_7

    Download citation

    • DOI: https://doi.org/10.1007/978-1-60327-267-4_7

    • Published:

    • Publisher Name: Humana Press

    • Print ISBN: 978-1-60327-266-7

    • Online ISBN: 978-1-60327-267-4

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics

    Search

    Navigation